| Business Summary | | Bayer
AG
is
an
international,
research-based
company
active
in
life
sciences,
polymers
and
chemicals.
Bayer
is
a
chemicals
and
healthcare
group
numbering
some
350
individual
companies,
represented
in
virtually
every
country
in
the
world.
The
cornerstones
of
its
business
activities
are
in
Europe,
North
America
and
the
Far
East.
The
Company's
operations
are
structured
into
four
business
segments:
Healthcare,
Agriculture,
Polymers
and
Chemicals,
which
comprise
15
business
groups. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bayer
AG
is
a
diversified,
international
chemical
and
pharmaceutical
company.
BAYZ
offers
products
and
services
in
areas
ranging
from
health
care
and
agriculture
to
plastics,
specialty
chemicals
and
imaging
technologies.
For
the
three
months
ended
3/31/01,
revenue
rose
10%
to
EUR7.66
billion.
Net
income
fell
21%
to
EUR442M.
Results
reflect
the
acquisition
of
the
polyols
business
of
Lyondell
Chemical's,
offset
by
the
persistently
high
level
of
raw
material
costs. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Manfred Schneider | Chairman | Pol Bamelis | Member
of the Board |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|